^
    CANCER:
    Fallopian Tube Cancer
    BRCA1 mutation
    Fallopian Tube Cancer
    BGB-290
    Sensitive
    :
    A1
    BeiGene Press Release - 4d
    BRCA2 mutation
    Fallopian Tube Cancer
    BGB-290
    Sensitive
    :
    A1
    BeiGene Press Release - 4d
    No biomarker
    Fallopian Tube Cancer
    bevacizumab + olaparib
    Sensitive
    :
    A2
    NICE - 1wk
    HRD
    Fallopian Tube Cancer
    bevacizumab + olaparib
    Sensitive
    :
    A1
    NICE - 1wk
    No biomarker
    Fallopian Tube Cancer
    niraparib
    Sensitive
    :
    A1
    No biomarker
    Fallopian Tube Cancer
    bevacizumab
    Sensitive
    :
    A1
    No biomarker
    Fallopian Tube Cancer
    Mvasi (bevacizumab biosimilar)
    Sensitive
    :
    A1
    No biomarker
    Fallopian Tube Cancer
    Aybintio (bevacizumab biosimilar)
    Sensitive
    :
    A1
    No biomarker
    Fallopian Tube Cancer
    Onbevzi (bevacizumab biosimilar)
    Sensitive
    :
    A1
    BRCA1 mutation
    Fallopian Tube Cancer
    rucaparib
    Sensitive
    :
    A1
    BRCA2 mutation
    Fallopian Tube Cancer
    rucaparib
    Sensitive
    :
    A1
    No biomarker
    Fallopian Tube Cancer
    rucaparib
    Sensitive
    :
    A1
    BRCA2 mutation
    Fallopian Tube Cancer
    bevacizumab + olaparib
    Sensitive
    :
    A1
    BRCA1 mutation
    Fallopian Tube Cancer
    bevacizumab + olaparib
    Sensitive
    :
    A1
    No biomarker
    Fallopian Tube Cancer
    olaparib
    Sensitive
    :
    A1
    BRCA1 mutation
    Fallopian Tube Cancer
    niraparib
    Sensitive
    :
    A1
    BRCA2 mutation
    Fallopian Tube Cancer
    niraparib
    Sensitive
    :
    A1
    HRD
    Fallopian Tube Cancer
    niraparib
    Sensitive
    :
    A1
    BRCA2 mutation
    Fallopian Tube Cancer
    olaparib
    Sensitive
    :
    A1
    BRCA1 mutation
    Fallopian Tube Cancer
    olaparib
    Sensitive
    :
    A1
    No biomarker
    Fallopian Tube Cancer
    carboplatin + micellar paclitaxel
    Sensitive
    :
    A1
    No biomarker
    Fallopian Tube Cancer
    Bevax (bevacizumab biosimilar)
    Sensitive
    :
    A1
    No biomarker
    Fallopian Tube Cancer
    CAPOX
    Sensitive
    :
    A2
    No biomarker
    Fallopian Tube Cancer
    sorafenib
    Sensitive
    :
    A2
    No biomarker
    Fallopian Tube Cancer
    topotecan
    Sensitive
    :
    A2
    No biomarker
    Fallopian Tube Cancer
    pegylated liposomal doxorubicin
    Sensitive
    :
    A2
    MSI-H/dMMR
    Fallopian Tube Cancer
    pembrolizumab
    Sensitive
    :
    A2
    NTRK3 fusion
    Fallopian Tube Cancer
    larotrectinib
    Sensitive
    :
    A2
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES